Instrument Inactif

Communiqués Arch Therapeutics, Inc. Other OTC

Actions

ARTH

US03939W1099

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)	06/05	AQ
Arch Therapeutics : New Financial Obligation - Form 8-K	03/04	PU
Arch Therapeutics : New Financial Obligation - Form 8-K	15/12	PU
Arch Therapeutics Provides Year End Operational Update	09/11	AQ
Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	02/11	AQ
Arch Therapeutics Provides AC5® Commercialization Update	13/09/23	AQ
Arch Therapeutics Completes Financing as Bridge to Uplisting	08/09/23	AQ
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)	25/04/23	AQ
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect	05/04/23	AQ
Arch Therapeutics : Material Agreement - Form 8-K	17/03/23	PU
Arch Therapeutics’ AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid Services	09/03/23	AQ
Arch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government Facilities	07/03/23	AQ
ARCH THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	16/02/23	AQ
Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System	18/01/23	AQ
ARCH THER : Modification to Rights of Security Holders - Form 8-K	17/01/23	PU
Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National Exchange	17/01/23	AQ
ARCH THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	28/12/22	AQ
The Centers for Medicare & Medicaid Services Makes Preliminary Recommendation to Establish New HCPCS Billing Code Dedicated to Arch Therapeutics’ AC5® Advanced Wound System	05/12/22	AQ
ARCH THERAPEUTICS, INC. : Other Events (form 8-K)	02/12/22	AQ
Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Fall	18/10/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Arch Therapeutics, Inc. Other OTC

Actions

ARTH

US03939W1099

Communiqués

Filtres